Author:
Tazuma Susumu, ,Igarashi Yoshinori,Inui Kazuo,Ohara Hirotaka,Tsuyuguchi Toshio,Ryozawa Shomei
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Committee on Guidelines for the Management of Acute Cholangitis. Guidelines for the management of acute cholangitis/cholecystitis. 1st ed. Tokyo: Igaku Tosho Shuppan; 2005.
2. Takada T, Kawarada Y, Nimura Y, et al. Background: Tokyo guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg. 2007;14:1–10.
3. Kanafani ZA, Khalife N, Kanj SS, et al. Antibiotic use in acute cholecystitis: practice patterns in the absence of evidence-based guidelines. J Infect. 2005;51:128–34.
4. Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-lactamase: implications for antibiotic use. Antimicrob Agents Chemother. 2008;52:995–1000.
5. Tazuma S, Iwamoto K, Hyogo H, et al. Clinical experience of injectable ciprofloxacin (CIP) for biliary tract infection. J Biliary Tract Pancreas. 2003;24:781–5.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献